Literature DB >> 15258617

A mechanism for the proapoptotic activity of ursodeoxycholic acid: effects on Bcl-2 conformation.

M Castelli1, J J Reiners, D Kessel.   

Abstract

Ursodeoxycholic acid (UDCA), a relatively nontoxic bile acid, enhanced the apoptotic response of tumor cells to both photosensitizers that cause photodamage to Bcl-2 and to the nonpeptidic Bcl-2/Bcl-x(L) antagonist HA14-1. The latter agent binds to the surface pocket formed by the BH1, BH2 and BH3 domains of Bcl-2 and Bcl-x(L). Fluorescence polarization studies indicated that affinity of HA14-1 for Bcl-2 was enhanced in the presence of UDCA. Moreover, Bcl-2 photodamage was promoted by UDCA using a photosensitizing agent with affinity for the endoplasmic reticulum, a site of Bcl-2 localization. Fluorescence resonance energy transfer (FRET) studies revealed that the proximity of Bcl-2 to a hydrophobic photosensitizing agent embedded in liposomes was enhanced by UDCA. Since photodamage will occur only if a protein is in close contact with a photosensitizing agent, we propose that these findings support the hypothesis that UDCA causes a conformational change in Bcl-2, promoting HA14-1 binding and enhancing affinity for certain membrane-bound photosensitizers.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15258617     DOI: 10.1038/sj.cdd.4401433

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  12 in total

1.  Protection of Bcl-2 by salubrinal.

Authors:  David Kessel
Journal:  Biochem Biophys Res Commun       Date:  2006-06-19       Impact factor: 3.575

2.  Bcl2 negatively regulates DNA double-strand-break repair through a nonhomologous end-joining pathway.

Authors:  Qinhong Wang; Fengqin Gao; W Stratford May; Yangde Zhang; Tammy Flagg; Xingming Deng
Journal:  Mol Cell       Date:  2008-02-29       Impact factor: 17.970

3.  Protein phosphatase 2A inactivates Bcl2's antiapoptotic function by dephosphorylation and up-regulation of Bcl2-p53 binding.

Authors:  Xingming Deng; Fengqin Gao; W Stratford May
Journal:  Blood       Date:  2008-10-09       Impact factor: 22.113

4.  Death pathways associated with photodynamic therapy.

Authors:  David Kessel
Journal:  Med Laser Appl       Date:  2006-11-15

5.  Small-Molecule Bcl2 BH4 Antagonist for Lung Cancer Therapy.

Authors:  Bingshe Han; Dongkyoo Park; Rui Li; Maohua Xie; Taofeek K Owonikoko; Guojing Zhang; Gabriel L Sica; Chunyong Ding; Jia Zhou; Andrew T Magis; Zhuo G Chen; Dong M Shin; Suresh S Ramalingam; Fadlo R Khuri; Walter J Curran; Xingming Deng
Journal:  Cancer Cell       Date:  2015-05-21       Impact factor: 31.743

6.  Sphingomyelins suppress the targeted disruption of lysosomes/endosomes by the photosensitizer NPe6 during photodynamic therapy.

Authors:  Joseph A Caruso; Patricia A Mathieu; John J Reiners
Journal:  Biochem J       Date:  2005-12-01       Impact factor: 3.857

7.  Bcl2 induces DNA replication stress by inhibiting ribonucleotide reductase.

Authors:  Maohua Xie; Yun Yen; Taofeek K Owonikoko; Suresh S Ramalingam; Fadlo R Khuri; Walter J Curran; Paul W Doetsch; Xingming Deng
Journal:  Cancer Res       Date:  2013-11-06       Impact factor: 12.701

8.  An anionic porphyrin binds beta-lactoglobulin A at a superficial site rich in lysine residues.

Authors:  Ivan Silva; Samuel Sansone; Lorenzo Brancaleon
Journal:  Protein J       Date:  2009-01       Impact factor: 2.371

Review 9.  Assessing autophagy in the context of photodynamic therapy.

Authors:  John J Reiners; Patrizia Agostinis; Kristian Berg; Nancy L Oleinick; David Kessel
Journal:  Autophagy       Date:  2010-01-01       Impact factor: 16.016

10.  Bcl2 inhibits abasic site repair by down-regulating APE1 endonuclease activity.

Authors:  Jinfeng Zhao; Fengqin Gao; Yangde Zhang; Kun Wei; Yunhai Liu; Xingming Deng
Journal:  J Biol Chem       Date:  2008-02-08       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.